S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Harvard Management Company/Q4 2021

Harvard Management Company

Period: Q4 2021 Β· Filed: 2022-02-11
View on SEC EDGAR β†—
AUM
$1.07B
Total portfolio value
Positions
46
Reported securities
Top Holding
LNWO
16.8% $179.0M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-02-11) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
LNWOSCIENTIFIC GAMES CORP$179.0M16.80%$66.83$72.79+8.9%
16.8%
GOOGLALPHABET INC$176.8M16.59%$143.58$359.91+150.7%
16.6%
RPRXROYALTY PHARMA PLC$138.1M12.96%$35.74$57.77+61.6%
13.0%
METAMETA PLATFORMS INC$125.2M11.75%$333.42$582.90+74.8%
11.8%
ABCLABCELLERA BIOLOGICS INC$58.7M5.51%$14.30$8.11-43.3%
5.5%
EQRXEQRX INC$35.9M3.37%β€”β€”
3.4%
TXG10X GENOMICS INC$27.7M2.60%$148.96$39.01-73.8%
2.6%
RXRXRECURSION PHARMACEUTICALS IN$25.9M2.43%$17.13$3.80-77.8%
2.4%
AFRMAFFIRM HLDGS INC$17.4M1.64%$100.56$84.58-15.9%
1.6%
RVMDREVOLUTION MEDICINES INC$16.9M1.58%$25.17$189.24+651.9%
1.6%
RLAYRELAY THERAPEUTICS INC$16.6M1.56%$30.71$18.65-39.3%
1.6%
PRAXPRAXIS PRECISION MEDICINES I$15.3M1.44%$295.50$318.52+7.8%
1.4%
GRABGRAB HOLDINGS LIMITED$14.3M1.34%$7.13$3.90-45.3%
1.3%
TNYATENAYA THERAPEUTICS INC$12.8M1.20%$18.95$0.79-95.8%
1.2%
RKLBXXXXROCKET LAB USA INC$12.3M1.15%β€”β€”
1.1%
MEKAMELI KASZEK PIONEER CORP$11.6M1.09%β€”β€”
1.1%
PCTPURECYCLE TECHNOLOGIES INC$10.2M0.96%$9.57$7.61-20.5%
1.0%
CFLTCONFLUENT INC$9.9M0.93%β€”β€”
0.9%
MUMICRON TECHNOLOGY INC$9.6M0.90%$91.07$975.56+971.2%
0.9%
NRIXNURIX THERAPEUTICS INC$9.1M0.86%$28.95$23.97-17.2%
0.9%
LRCXXXXXLAM RESEARCH CORP$9.0M0.85%β€”β€”
0.8%
KNTEKINNATE BIOPHARMA INC$8.8M0.83%β€”β€”
0.8%
AMATAPPLIED MATLS INC$8.0M0.75%$151.39$603.04+298.3%
0.8%
AMDADVANCED MICRO DEVICES INC$7.9M0.74%$143.90$517.82+259.9%
0.7%
INTCINTEL CORP$7.8M0.73%$47.76$120.35+152.0%
0.7%
TSMTAIWAN SEMICONDUCTOR MFG LTD$7.8M0.73%$111.82$434.16+288.3%
0.7%
TNGXTANGO THERAPEUTICS INC$7.8M0.73%$10.94$29.46+169.3%
0.7%
NVDANVIDIA CORPORATION$7.7M0.73%$29.32$194.83+564.5%
0.7%
PLRXPLIANT THERAPEUTICS INC$7.6M0.71%$13.50$1.17-91.3%
0.7%
QRVOQORVO INC$7.3M0.69%$156.39$87.57-44.0%
0.7%

Quarter-on-Quarter Activity

Q4 2021 vs. Q3 2021

New Positions (8)

TickerIssuerNotionalSince Filing
EQRXEQRX INC$35.9M
GRABGRAB HOLDINGS LIMITED$14.3M-45.3%
CFLTCONFLUENT INC$9.9M
MUMICRON TECHNOLOGY INC$9.6M+971.2%
LRCXXXXXLAM RESEARCH CORP$9.0M
AMATAPPLIED MATLS INC$8.0M+298.3%
AMDADVANCED MICRO DEVICES INC$7.9M+259.9%
INTCINTEL CORP$7.8M+152.0%

Exited Positions (8)

TickerIssuerNotional
AAPLAPPLE INC$266.5M
QQQINVESCO QQQ TR$36.3M
IVVISHARES TR$28.1M
GLDSPDR GOLD TR$15.1M
VEAVANGUARD TAX-MANAGED INTL FD$8.2M
IJRISHARES TR$5.4M
FSIIFS DEVELOPMENT CORP II$4.0M
VWOVANGUARD INTL EQUITY INDEX F$3.7M

Increased

None this quarter

Trimmed (5)

TickerIssuerNotionalShares Ξ”Since Filing
AFRMAFFIRM HLDGS INC$-72.3M-77.0%-15.9%
SANASANA BIOTECHNOLOGY INC$-18.9M-59.7%
RPRXROYALTY PHARMA PLC$-120.1M-51.5%+61.6%
METAMETA PLATFORMS INC$-116.8M-47.8%+74.8%
GOOGLALPHABET INC$13.5M-0.1%+150.7%
← Back to Hedge Funds